KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,292,487 | +3.9% | 213,477 | -13.0% | 0.06% | -1.8% |
| Q1 2023 | $44,558,835 | +98370.4% | 245,314 | +6.5% | 0.06% | -13.8% |
| Q4 2022 | $45,251 | -99.8% | 230,284 | +85.5% | 0.06% | +58.5% |
| Q3 2022 | $27,928,000 | +84.4% | 124,161 | +3.7% | 0.04% | +95.2% |
| Q2 2022 | $15,147,000 | -0.6% | 119,731 | -0.4% | 0.02% | +23.5% |
| Q1 2022 | $15,246,000 | -40.6% | 120,245 | -38.6% | 0.02% | -34.6% |
| Q4 2021 | $25,654,000 | -39.3% | 195,830 | -43.3% | 0.03% | -44.7% |
| Q3 2021 | $42,249,000 | – | 345,371 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |